HOTH News and Press, Hoth Therapeutics Inc. From 04/10/23

2023-04-10 14:26:22 ET "Naked Short Selling: What It Is and How It Works." For further details see: SMX Security Matters to probe suspected illegal trading, shares soar

Hoth Therapeutics Announces Collaboration with First Active Clinical Site for its Phase 2 Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy PR Newswire NEW YORK , March 8, 2023 /PRNewswire/ -- Hoth Therapeut...

3 Reasons Why Penny Stocks Are Worth Buying Right Now Penny stocks are a hot topic for investors looking to make big profits with small investments. These are low-priced stocks that trade outside the major exchanges, and they can be quite volatile. Many investors shy away from penny stocks ...

Nano-cap pharma Hoth Therapeutics ( NASDAQ: HOTH ) climbed ~26% on Thursday after announcing an agreement with Shareholder Intelligence Services, LLC (ShareIntel) to monitor key shareholder activities and take action against naked short selling. More than 6M Hoth ( HOTH ) shar...

Hoth Therapeutics Retains ShareIntel to Investigate Illegal Naked Shorting Activity PR Newswire Strengthens Measures to Safeguard Shareholder Interests through ShareIntel's Investigation and Due Diligence Services for Illegal Short Selling NEW YORK , Feb. 16, 202...

Hoth Therapeutics ( NASDAQ: HOTH ) stock rose ~20% on Wednesday after it reported proof-of-concept data for Alzheimer's disease (AD) drug HT-ALZ in mouse model. The company said the proof-of-concept data was generated using cognitive and behavioral assessments in an...

Hoth Therapeutics Announces Increased Positive Results of its Alzheimer's Therapeutic HT-ALZ PR Newswire HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer's Disease Mouse Model and Results Show Reduced Anxiety and Improved Performance NEW YORK ...

Hoth Therapeutics Announces Selection of First 3 Clinical Sites for its Phase 2 Clinical Trial to Treat Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy PR Newswire Patient Recruitment Underway NEW YORK , Jan. 25, 202...

Hoth Therapeutics Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules PR Newswire NEW YORK , Jan. 3, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company" or "Hoth"), a patient-focused biopharmaceutical ...

Palm Beach, FL – December 30, 2022 – FinancialNewsMedia.com News Commentary – According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million people. The global rheumatoid arthritis drugs market is ...